Data Section

Corporate Information/Stock Information (As of March 31, 2023)
Corporate Information

The Role of Integrated Report

External Evaluations/
Commitment to External Initiatives(As of July 2023)

Company Name

Olympus Corporation

Established

October 12, 1919

Head Office

Shinjuku Monolith, 3-1
Nishi-Shinjuku 2-chome, Shinjuku-ku,
Tokyo 163-0914, Japan

Capital¥124,643 million

Number of Group Companies

108 (Excluding Olympus Corporation, 105
Subsidiaries, and 3 Affiliates)

Consolidated Headcount32,805 (Excludes temporary employees,average of 786)

Non-Consolidated Headcount

2,727

Websitehttps://www.olympus-global.com

Securities Identification Code7733

Stock Exchange Listing

Tokyo Stock Exchange

Fiscal Year-End

March 31

General Meeting ofShareholders

JuneShare Trading Unit

100

Number of Shares Issued

1,266,178,700

Number of Shareholders

58,910Transfer Agent for
Common Stock

Sumitomo Mitsui Trust Bank, Limited
4-1, Marunouchi 1-chome, Chiyoda-ku,
Tokyo 100-8233, Japan

Inclusion in ESG Indexes

Dow Jones Sustainability World Index
Dow Jones Sustainability Asia Pacific Index

Olympus Global Homepage

FTSE4Good Index Series
FTSE Blossom Japan Index
FTSE Blossom Japan Sector Relative Index

Financial

Provides informationon the Olympus Groupsuch as management
information, productinformation, andnon-financial
information.

Secured an “A+” rating from Rating andInvestment Information, Inc. (R&I).

Secured a “BBB+” rating from S&P Global
Ratings Japan Inc. (S&P)
Secured a “Baa2” rating from Moody’s
Japan K.K. (Moody’s)

ESG
https://www.
olympus-global.com

Sustainability
Presents theOlympus Group’s
detailed ESG
information.

Obtained a A- rating in the climate change
survey and a B rating in the water security
survey by CDP Worldwide, an international
NGO that aims at the realization of asustainable economy (2022 for Olympus).

Listed in White 500, the CertifiedHealth and Productivity Management
Organization Recognition Program(seven consecutive years since 2017for Olympus and 2021 for Olympus
Marketing).

Selected by CDP as a CDP 2022 Supplier
Engagement Leader, the highest rating in theSupplier Engagement Rating (SER), which
evaluates how effectively companies areworking with their suppliers to address
climate change challenges (two consecutiveyears since 2021 for Olympus).

Listed in the Certified Health andProductivity Management
Organization Recognition Program(three consecutive years since 2021
for Aizu Olympus and in 2020, 2022,and 2023 for Olympus Marketing).

Received Platinum Kurumin certification from
the Ministry of Health, Labour and Welfare asa company with excellent initiatives tocombine work and childcare and to promote
ongoing initiatives (Olympus in 2022, andOlympus Terumo Biomaterials in 2021).
Received Kurumin certification from theMinistry of Health, Labour and Welfare as acompany with excellent initiatives to combine
work and childcare (Olympus Marketing in2020, and Aizu Olympus 2022).

Received Eruboshi certification from
the Minister of Health, Labour andWelfare as a company that activelypromotes women workers (Eruboshi
Grade 3 for Olympus in 2019).

Received the Silver rating under the PRIDE
Index 2022, a Japanese index to evaluate a
corporation’s performance in LGBTQ
inclusion (2022 for Olympus).

Support for the Recommendations ofthe Task Force on Climate-related
Financial Disclosures (TCFD).

Certified as a Sports Yell Company (2023 forOlympus, Olympus Marketing and Olympus
Terumo Biomaterials).

Participates in the United Nations
Global Compact.

Composition ofShareholders

Principal Shareholders

Number ofshares held

Percentage ofshares outstanding

The Master Trust Bank of Japan, Ltd.
(trust accounts)

259,260,800

20.68%

Custody Bank of Japan, Ltd. (trust accounts)

96,219,200

7.68%

JP MORGAN CHASE BANK 385632

81,646,548

6.51%

SSBTC CLIENT OMNIBUS ACCOUNT

52,109,662

4.16%

Shareholder name

This Integrated Report compiles important informationthat includes non-financial information in addition tofinancial information and aims to provide aneasy-to-understand explanation of the value Olympus
creates. For more detailed information, please refer tothe following corporate websites and media.

2.54%
4.83%39,509,300

3.15%

Nippon Life Insurance Company

21,258,572

1.70%

STATE STREET BANK WEST
CLIENT-TREATY 505234

21,097,112

1.68%

MUFG Bank, Ltd.

17,522,344

1.40%

JP MORGAN CHASE BANK 385781

16,538,901

1.32%

THE BANK OF NEW YORK MELLON AS
DEPOSITARY BANK FOR DEPOSITARYRECEIPT HOLDERS

16,043,055

1.28%

1.00%
Olympus Medical Business

38.37%SMBC Trust Bank Ltd.
(Sumitomo Mitsui Banking Corporation’s
retirement benefit trust account)

2.11%

https://www.
olympus-global.
com/csr/

51.15%

Introduces Olympus’
strengths in as well asbasic knowledge
about the MedicalBusiness.

https://www.olympus-global.
com/ir/data/medical.html
Foreign institutions and individuals
Japanese financial Institutions
Japanese individuals and others
Japanese securities firms
Other Japanese corporations
Treasury stock

MEDICAL
BUSINESS
Olympus Medical BusinessNote: The holding ratio is computed by excluding treasury stock (12,641,218).

106

Olympus Integrated Report 2023

103